Riboxin Reneval, 200 mg 50 pcs

Pharmacotherapeutic group: metabolic agent.

The ATX code: C01EB

Pharmacological properties

Pharmacodynamics

Inosine is a derivative (nucleoside) of purine, precursor of adenosine triphosphate (ATP). It belongs to the group of drugs stimulating metabolic processes. It has antihypoxic and antiarrhythmic effects. It increases myocardial energy balance, improves coronary circulation, and prevents the consequences of intraoperative renal ischemia. It is directly involved in glucose metabolism and promotes metabolism in hypoxia and in the absence of ATP.

It also activates pyruvic acid metabolism, which is necessary for normal tissue respiration, and helps activation of xanthine dehydrogenase. It stimulates the synthesis of nucleotides and enhances the activity of some Krebs cycle enzymes. By penetrating into cells, it has a positive effect on metabolic processes in the myocardium: it increases the force of heart contractions and promotes fuller myocardial relaxation in diastole, resulting in an increase in stroke volume. The mechanism of antiarrhythmic action is not fully understood.

Limits platelet aggregation, activates tissue regeneration (especially myocardium and gastrointestinal mucosa).

Pharmacokinetics

It is well absorbed in the gastrointestinal tract. It is metabolized in the liver with the formation of glucuronic acid and its subsequent oxidation. A small amount is excreted by the kidneys.

Indications

Active ingredient

Composition

How to take, the dosage

Interaction

Special Instructions

Influence on driving and operating machinery

It does not affect the ability to drive vehicles and operate mechanisms requiring increased concentration.

Synopsis

Contraindications

Hypersensitivity to inosine or other ingredients of the drug;

With caution

Renal insufficiency.

Side effects

Overdose

Pregnancy use

Similarities